In vivo efficacy of fidaxomicin against rpoB mutant Clostridioides difficile infection.
Mai Thu Hoai, Yutaro Hitomi, Tsutomu Fujii, Yoshitomo Morinaga
This study evaluates the in vivo efficacy of fidaxomicin against a rpoB mutant strain of C. difficile and finds it remains effective despite reduced susceptibility.
Anaerobe · Sep 3, 2025Peer-reviewedMicrobiology